JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
about
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
JCOG0911 INTEGRA study: a rand ...... newly diagnosed glioblastoma.
@en
JCOG0911 INTEGRA study: a rand ...... newly diagnosed glioblastoma.
@nl
type
label
JCOG0911 INTEGRA study: a rand ...... newly diagnosed glioblastoma.
@en
JCOG0911 INTEGRA study: a rand ...... newly diagnosed glioblastoma.
@nl
prefLabel
JCOG0911 INTEGRA study: a rand ...... newly diagnosed glioblastoma.
@en
JCOG0911 INTEGRA study: a rand ...... newly diagnosed glioblastoma.
@nl
P2093
P2860
P1476
JCOG0911 INTEGRA study: a rand ...... r newly diagnosed glioblastoma
@en
P2093
Akira Matsumura
Akitake Mukasa
Atsuo Yoshino
Eiichi Ishikawa
Fumiyuki Yamasaki
Haruhiko Fukuda
Hideo Nakamura
Hikaru Sasaki
Hirofumi Hirano
P2860
P2888
P304
P356
10.1007/S11060-018-2831-7
P577
2018-03-20T00:00:00Z